₹1,402.70
₹-19.30 (-1.36%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹1,13,778 Cr
P/E
33.90
ROE
11.27%
ROCE
14.95%
About Cipla Ltd
Cipla a leading Indian multinational pharmaceutical and biotechnology company headquartered in Mumbai, Maharashtra.
Founded
1935
CEO
Y K Hamied
Employees
47,496
HQ
Mumbai, Maharashtra
About Cipla Ltd
Cipla a leading Indian multinational pharmaceutical and biotechnology company headquartered in Mumbai, Maharashtra.
Founded:1935
CEO:Y K Hamied
Employees:47,496
HQ:Mumbai, Maharashtra
Finished Products
1Sales
₹64,158.78Cr2Royalty
₹6,438.76Cr3Other Operating Revenue
₹1,109.02Cr4Export Incentives
₹267.64Cr5Scrap Sales
₹166.70Cr6GST area Based Incentive
₹113.11Cr7Technical Know-how fees
₹90.61Cr1–7 of 9
Raw Materials
1Raw Materials Consumed
₹17,371.85Cr2Purchases of Traded Goods
₹11,849.37CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹1,673
52W Low
₹1,166
Volume915.49K
Avg VolumeN/A
Beta0.59
Dividend Yield0.92%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
33.90x
Valuation
P/B Ratio
3.30x
Valuation
EPS
₹41.54
Valuation
Dividend Yield
0.92%
Valuation
ROE
11.27%
Profitability
ROCE
14.95%
Profitability
Revenue by Segment
Contribution & growth by business line
Pharmaceuticals
+6.4%95.3%
₹26,244.26 Cr
New ventures
+17.2%4.7%
₹1,303.36 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
45.0%
International
55.0%
India45.0%
United States of America24.4%
Rest of the World15.4%
One Africa15.2%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.02x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
3.3%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.